Rachel L. Harris

发表

Is trisomy 5 a distinct cytogenetic subgroup in acute lymphoblastic leukemia?

C. Harrison, A. Moorman, M. Martineau, 2004, Cancer genetics and cytogenetics.

MLL translocations with concurrent 3′ deletions: Interpretation of FISH results

C. Harrison, A. Moorman, A. Ford, 2004, Genes, chromosomes & cancer.

Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemia

S. Richards, A. Vora, A. Moorman, 2004, British journal of haematology.

Outcome heterogeneity in childhood high-hyperdiploid acute lymphoblastic leukemia.

S. Richards, C. Harrison, A. Moorman, 2003, Blood.

Interphase molecular cytogenetic screening for chromosomal abnormalities of prognostic significance in childhood acute lymphoblastic leukaemia: a UK Cancer Cytogenetics Group Study

F. Ross, C. Harrison, A. Moorman, 2005, British journal of haematology.

Amplification of AML1 in acute lymphoblastic leukemia is associated with a poor outcome

S. Richards, C. Harrison, A. Moorman, 2003, Leukemia.

Short communication Is trisomy 5 a distinct cytogenetic subgroup in acute lymphoblastic leukemia

C. Harrison, A. Moorman, M. Martineau, 2004 .

Derivative chromosome 9 deletions are a significant feature of childhood Philadelphia chromosome positive acute lymphoblastic leukaemia

C. Harrison, A. Moorman, J. Strefford, 2005, Leukemia.

Amplification of the ABL gene in T-cell acute lymphoblastic leukemia

E. Cameron, C. Harrison, A. Moorman, 2004, Leukemia.